FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula 
(I) capable of bonding with S1P receptor (specifically EDG-6, preferably EDG-1 and EDG-6), its non-toxic water-insoluble salts or its methyl or ethyl ester.
EFFECT: obtaining compounds which can be used in preventing and/or treating graft rejection, graft-versus-host diseases, autoimmune diseases and allergic diseases.
11 cl, 66 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVE OF AMINOCARBON ACID AND APPLICATION OF SAID SUBSTANCES FOR MEDICAL PURPOSES | 2005 |
|
RU2433121C2 |
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND MEDICAMENTS THEREOF AS ACTIVE INGREDIENT | 2004 |
|
RU2366655C2 |
| TETRAHYDROCARBOLINE DERIVATIVE | 2011 |
|
RU2572818C2 |
| PHENYL DERIVATIVES | 2012 |
|
RU2619105C2 |
| SPIROKETAL DERIVATIVES AND USE THEREOF AS MEDICINAL AGENT AGAINST DIABETES | 2006 |
|
RU2416617C2 |
| 8-AZAPROSTAGLANDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND AGENT FOR PROPHYLAXIS OF DISEASES | 2003 |
|
RU2306309C2 |
| NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
| COMPOUND WITH STING AGONISTIC ACTIVITY | 2019 |
|
RU2798265C2 |
| DERIVATIVE OF CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION AND MEDICINE OF PREVENTING AND/OR CURING DISEASES, CAUSED BY ACTIVATION OF DP RECEPTOR, USE OF SUCH DERIVATIVE FOR MAKING SUCH MEDICINE, METHOD OF PREVENTING AND/OR CURING DISEASES, CAUSED BY ACTIVATION OF DP RECEPTORS | 2003 |
|
RU2329256C2 |
| SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2013 |
|
RU2607081C2 |
